Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination (ECVM)First published 01/04/2021 Last updated 23/04/2024 EU PAS number: EUPAS40404StudyFinalisedDownload as PDF
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
Division of Pharmacoepidemiology & Clinical Pharmacology (PECP), Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht UniversityNetherlands First published: 01/03/2010Last updated 16/04/2024 InstitutionEducational InstitutionENCePP partner
Pharmacoepidemiology and Pharmacovigilance department, Spanish Agency of medicines and medical devices (AEMPS)Spain First published: 31/07/2014Last updated 18/10/2018 InstitutionRegulatory AuthorityEU Institution/Body/AgencyNot-for-profitENCePP partner
University Medical Center Utrecht (UMCU)Netherlands First published: 24/11/2021Last updated 22/02/2024 InstitutionEducational InstitutionHospital/Clinic/Other health care facilityENCePP partner
The PHARMO Institute for Drug Outcomes Research (PHARMO Institute)Netherlands First published: 07/01/2022Last updated 10/01/2022 InstitutionLaboratory/Research/Testing facilityENCePP partner
Vaccine monitoring Collaboration for Europe (VAC4EU)BelgiumDenmarkFinlandFranceGermanyItalyNetherlandsNorwaySpainUnited Kingdom First published: 22/09/2020Last updated 22/09/2020 NetworkENCePP partner
EU Pharmacoepidemiology and Pharmacovigilance (PE&PV) Research NetworkNetherlands First published: 01/02/2024Last updated 12/03/2024 Network